Skip to main content

Table 3 Probability of death of patients from the two trial arms, sorted by tumour size, at different follow-up times (95% confidence intervals in parenthesis)

From: Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline

 

Years of follow-up

5

10

15

Controls, T1

0.26 (0.20-0.33)

0.47 (0.39-0.55)

0.64 (0.56-0.72)

Controls, T2/T3

0.38 (0.31-0.46)

0.58 (0.49-0.66)

0.68 (0.60-0.76)

CMF, T1

0.22 (0.16-0.28)

0.41 (0.33-0.48)

0.56 (0.48-0.64)

CMF, T2/T3

0.33 (0.26-0.40)

0.51 (0.44-0.59)

0.61 (0.53-0.68)